{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:14:28Z","timestamp":1790280868785,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroimaging Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.nic.2025.09.007","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:20:56Z","timestamp":1763702456000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes to the World Health Organization Classification for Pediatric Brain and Spine Tumors"],"prefix":"10.1016","volume":"36","author":[{"given":"Vanesha","family":"Naidu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Laughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nic.2025.09.007_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.nic.2025.09.007_bib2","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00234-022-03008-6","article-title":"2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist","volume":"64","author":"McNamara","year":"2022","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.nic.2025.09.007_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1148\/radiol.213063","article-title":"A Radiologist\u2019s guide to the 2021 WHO central nervous system tumor classification: part i-key concepts and the spectrum of diffuse gliomas","volume":"304","author":"Johnson","year":"2022","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.nic.2025.09.007_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10014-022-00428-3","article-title":"The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles","volume":"39","author":"Komori","year":"2022","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"10.1016\/j.nic.2025.09.007_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00247-022-05546-w","article-title":"Changes to pediatric brain tumors in 2021 world Health Organization classification of tumors of the central nervous system","volume":"53","author":"Oztek","year":"2023","journal-title":"Pediatr Radiol"},{"issue":"2","key":"10.1016\/j.nic.2025.09.007_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5114\/fn.2022.118183","article-title":"WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation","volume":"60","author":"Sejda","year":"2022","journal-title":"Folia Neuropathol"},{"issue":"4","key":"10.1016\/j.nic.2025.09.007_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3174\/ajnr.A7827","article-title":"Newly recognized CNS tumors in the 2021 world Health Organization classification: imaging overview with histopathologic and genetic correlation","volume":"44","author":"Rigsby","year":"2023","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.nic.2025.09.007_bib8","unstructured":"Central Nervous system tumours: WHO classification of tumours. WHO Classification of Tumours; 2022."},{"issue":"2","key":"10.1016\/j.nic.2025.09.007_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/2159-8290.CD-21-1094","article-title":"A summary of the inaugural WHO classification of pediatric tumors: transitioning from the optical into the molecular era","volume":"12","author":"Pfister","year":"2022","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.nic.2025.09.007_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12061349","article-title":"The 2021 World Health Organization central nervous system tumor classification: the spectrum of diffuse gliomas","volume":"12","author":"Gue","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/cco-22-120","article-title":"2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review","volume":"12","author":"Thomas","year":"2023","journal-title":"Chin Clin Oncol"},{"issue":"4","key":"10.1016\/j.nic.2025.09.007_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41388-021-02102-y","article-title":"Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies","volume":"41","author":"Findlay","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.nic.2025.09.007_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1268038","article-title":"Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists? Review","volume":"17","author":"d\u2019Amati","year":"2024","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"10.1016\/j.nic.2025.09.007_bib14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00401-020-02142-w","article-title":"Histone H3 wild-type DIPG\/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation","volume":"139","author":"Castel","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nic.2025.09.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0269-0","article-title":"Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics","volume":"4","author":"Hoffman","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"10.1016\/j.nic.2025.09.007_bib16","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/neuonc\/noaa024","article-title":"High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts","volume":"22","author":"Roux","year":"2020","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.nic.2025.09.007_bib17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00401-020-02155-5","article-title":"Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition","volume":"139","author":"Mondal","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-015-1493-1","article-title":"Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity","volume":"131","author":"Korshunov","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib19","article-title":"Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults","volume":"3","author":"Picart","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jon.12939","article-title":"Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: a case series and systematic review","volume":"32","author":"Kurokawa","year":"2022","journal-title":"J Neuroimaging"},{"issue":"2","key":"10.1016\/j.nic.2025.09.007_bib21","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230777","article-title":"Brain tumor imaging in adolescents and young adults: 2021 WHO updates for molecular-based tumor types","volume":"310","author":"Wagner","year":"2024","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.nic.2025.09.007_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10014-017-0287-7","article-title":"Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution","volume":"34","author":"Yoshimoto","year":"2017","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"10.1016\/j.nic.2025.09.007_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00401-017-1710-1","article-title":"H3-\/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers","volume":"134","author":"Korshunov","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib24","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-021-25709-x","article-title":"Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma","volume":"12","author":"DeSisto","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.nic.2025.09.007_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/genes13040624","article-title":"Pediatric high grade glioma classification criteria and molecular features of a case series","volume":"13","author":"Buccoliero","year":"2022","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib26","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-019-12187-5","article-title":"Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas","volume":"10","author":"Guerreiro Stucklin","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.nic.2025.09.007_bib27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1158\/2159-8290.CD-19-1030","article-title":"Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes","volume":"10","author":"Clarke","year":"2020","journal-title":"Cancer Discov"},{"issue":"suppl_4","key":"10.1016\/j.nic.2025.09.007_bib28","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nic.2025.09.007_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-016-1639-9","article-title":"Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway","volume":"133","author":"Huse","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12883-020-01679-3","article-title":"Polymorphous low-grade neuroepithelial tumor of the young: case report and review focus on the radiological features and genetic alterations","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40478-020-00902-z","article-title":"Pediatric low-grade glioma in the era of molecular diagnostics","volume":"8","author":"Ryall","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"issue":"7","key":"10.1016\/j.nic.2025.09.007_bib32","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3174\/ajnr.A7462","article-title":"The 2021 world Health Organization Classification of tumors of the central nervous system: what neuroradiologists need to know","volume":"43","author":"Osborn","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.nic.2025.09.007_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.nic.2025.09.007_bib34","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/modpathol.2008.88","article-title":"Clinicopathological features and global genomic copy number alterations of pilomyxoid astrocytoma in the hypothalamus\/optic pathway: comparative analysis with pilocytic astrocytoma using array-based comparative genomic hybridization","volume":"21","author":"Jeon","year":"2008","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.nic.2025.09.007_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00401-018-1837-8","article-title":"Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A\/B and ATRX alterations","volume":"136","author":"Reinhardt","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.nic.2025.09.007_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/bpa.12217","article-title":"Pleomorphic xanthoastrocytoma: natural history and long-term Follow-Up","volume":"25","author":"Ida","year":"2015","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nic.2025.09.007_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12957-015-0603-9","article-title":"Chordoid glioma: a rare radiologically, histologically, and clinically mystifying lesion","volume":"13","author":"Bongetta","year":"2015","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.nic.2025.09.007_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1750-3639.2000.tb00266.x","article-title":"Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization","volume":"10","author":"Brat","year":"2000","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archneur.1994.00540130110018","article-title":"Tuberous sclerosis in Western Sweden. A population study of cases with early childhood onset","volume":"51","author":"Ahls\u00e9n","year":"1994","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncr.33918","article-title":"Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system","volume":"128","author":"Gritsch","year":"2022","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.nic.2025.09.007_bib41","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s00381-024-06502-9","article-title":"Imaging of pediatric glioneuronal and neuronal tumors","volume":"40","author":"Pai","year":"2024","journal-title":"Childs Nerv Syst"},{"issue":"Supplement","key":"10.1016\/j.nic.2025.09.007_bib42","first-page":"S59","article-title":"Glioneuronal and neuronal tumors: a review with special reference to the new types in the WHO CNS5 classification","volume":"65","author":"Komori","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"10.1016\/j.nic.2025.09.007_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-020-02169-z","article-title":"CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort","volume":"140","author":"J\u00fcnger","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nic.2025.09.007_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bpa.12659","article-title":"Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features","volume":"29","author":"Andreiuolo","year":"2019","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.nic.2025.09.007_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","article-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","volume":"20","author":"Witt","year":"2011","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.nic.2025.09.007_bib46","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221885","article-title":"A radiologist\u2019s guide to the 2021 WHO central nervous System tumor classification: part 2-Newly described and revised tumor types","volume":"307","author":"Guerin","year":"2023","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-015-1955-2","article-title":"Myxopapillary ependymomas in children: imaging, treatment and outcomes","volume":"126","author":"Bandopadhayay","year":"2016","journal-title":"J Neuro Oncol"},{"issue":"4","key":"10.1016\/j.nic.2025.09.007_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13068","article-title":"Updates in the classification of ependymal neoplasms: the 2021 WHO classification and beyond","volume":"32","author":"Kresbach","year":"2022","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.nic.2025.09.007_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13059","article-title":"Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - advances in diagnosis and prognostication","volume":"32","author":"Meredith","year":"2022","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.nic.2025.09.007_bib50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s40478-020-01064-8","article-title":"The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of \u201cCNS tumors with BCOR internal tandem duplication\u201d","volume":"8","author":"Tauzi\u00e8de-Espariat","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"10.1016\/j.nic.2025.09.007_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12918","article-title":"Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms","volume":"31","author":"Sloan","year":"2021","journal-title":"Brain Pathol"},{"issue":"10","key":"10.1016\/j.nic.2025.09.007_bib52","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/s41379-020-0516-1","article-title":"DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor","volume":"33","author":"Kamihara","year":"2020","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.nic.2025.09.007_bib53","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1148\/rg.210236","article-title":"Major changes in 2021 world Health Organization classification of central nervous System tumors","volume":"42","author":"Kurokawa","year":"2022","journal-title":"Radiographics"},{"issue":"9","key":"10.1016\/j.nic.2025.09.007_bib54","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00701-022-05301-y","article-title":"The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know-a minireview","volume":"164","author":"Torp","year":"2022","journal-title":"Acta Neurochir"},{"issue":"6","key":"10.1016\/j.nic.2025.09.007_bib55","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s13311-022-01249-0","article-title":"Major features of the 2021 WHO classification of CNS tumors","volume":"19","author":"Smith","year":"2022","journal-title":"Neurotherapeutics"}],"container-title":["Neuroimaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514925008391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514925008391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:22:20Z","timestamp":1763702540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052514925008391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1052514925008391"],"URL":"https:\/\/doi.org\/10.1016\/j.nic.2025.09.007","relation":{},"ISSN":["1052-5149"],"issn-type":[{"value":"1052-5149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes to the World Health Organization Classification for Pediatric Brain and Spine Tumors","name":"articletitle","label":"Article Title"},{"value":"Neuroimaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nic.2025.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}